CASC15 participated in the damage of vascular endothelial cells in atherosclerosis through interaction with miR-940

Tairan Li1, Zhaolan Yang2, Kun Zhang3

  • 1Department of Cardiovascular Medicine, Shenzhen Guangming District People's Hospital, Shenzhen, 518107, China.

BMC Medical Genomics
|October 7, 2025
PubMed
Abstract

Insights

Inhibition of long non-coding RNA CASC15 alleviates atherosclerosis by promoting autophagy via miR-940. This finding offers a potential therapeutic target for endothelial dysfunction.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Cell Biology

Background:

  • Atherosclerosis (AS) is a complex cardiovascular disease.
  • Long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) are implicated in AS pathogenesis.
  • The specific roles of lncRNA CASC15 and miR-940 in AS require further elucidation.

Purpose of the Study:

  • To investigate the roles of lncRNA CASC15 and miR-940 in an in vitro model of AS.
  • To explore the underlying molecular mechanisms, particularly focusing on autophagy regulation.

Main Methods:

  • Established an in vitro AS model using oxidized low-density lipoprotein (ox-LDL)-treated human umbilical vein endothelial cells (HUVECs).
  • Quantified expression levels of CASC15, miR-940, adhesion molecules (ICAM-1, VCAM-1), and inflammatory cytokines (IL-1β, IL-6, TNF-α).
  • Assessed cell viability, apoptosis, and autophagy flux, utilizing bioinformatics for target gene prediction.

Main Results:

  • Ox-LDL induction increased CASC15 expression and decreased miR-940 expression in HUVECs.
  • CASC15 acts as a sponge for miR-940, and miR-940 is a downstream target of CASC15.
  • Inhibition of CASC15 promoted autophagy, alleviated endothelial dysfunction, reduced apoptosis, and decreased inflammation, while decreased miR-940 exacerbated these effects.
  • Autophagy activation ameliorated ox-LDL-induced endothelial dysfunction, confirming the CASC15/miR-940 axis's role in regulating autophagy and endothelial function.

Conclusions:

  • lncRNA CASC15 inhibition ameliorates ox-LDL-induced endothelial dysfunction.
  • This protective effect is mediated through the promotion of autophagy via the modulation of miR-940.
  • The CASC15/miR-940/autophagy pathway represents a potential therapeutic target for atherosclerosis.